113 related articles for article (PubMed ID: 16782551)
1. Sublingual immunotherapy induces spirometric improvement associated with IL-10 production: preliminary reports.
Ciprandi G; Cirillo I; Fenoglio D; Marseglia G; Tosca MA
Int Immunopharmacol; 2006 Aug; 6(8):1370-3. PubMed ID: 16782551
[TBL] [Abstract][Full Text] [Related]
2. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.
Ciprandi G; Fenoglio D; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Puppo F
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):38-44. PubMed ID: 16095140
[TBL] [Abstract][Full Text] [Related]
3. Sublingual specific immunotherapy reduces PBMC proliferations.
Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy-induced IL-10 production is associated with changed response to the decongestion test: preliminary results.
Ciprandi G; Cirillo I; Tosca MA; Marseglia G; Fenoglio D
Allergy Asthma Proc; 2007; 28(5):574-7. PubMed ID: 18034978
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy provides an early increase of interferon-gamma production.
Ciprandi G; Fenoglio D; Di Gioacchino M; Ferrera A; Ferrera F; Sormani MP; Marseglia GL
J Biol Regul Homeost Agents; 2008; 22(3):169-73. PubMed ID: 18842170
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
Li TY; Chen DH; Lin ZB; Xu R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
12. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
Canonica GW; Passalacqua G
Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life.
Marogna M; Bruno M; Massolo A; Falagiani P
Int Arch Allergy Immunol; 2007; 142(1):70-8. PubMed ID: 17016060
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-4 as a marker of immunological response to sublingual immunotherapy.
Ciprandi G; De Amici M; Murdaca G; Colombo BM; Quaglini S; Marseglia G; Di Gioacchino M
J Biol Regul Homeost Agents; 2008; 22(2):117-23. PubMed ID: 18597704
[TBL] [Abstract][Full Text] [Related]
17. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy for allergic respiratory disease in elderly patients: a retrospective study.
Marogna M; Bruno ME; Massolo A; Falagiani P
Eur Ann Allergy Clin Immunol; 2008 May; 40(1):22-9. PubMed ID: 18700331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
